BRPI1008188A2 - "derivados de 6-(6-nh-subistituído-triazolopiridazina-sulfanil) benzotiazóis e benzimidazóis: preparo, aplicação como medicamentos e utilização como inibidores de met" - Google Patents
"derivados de 6-(6-nh-subistituído-triazolopiridazina-sulfanil) benzotiazóis e benzimidazóis: preparo, aplicação como medicamentos e utilização como inibidores de met"Info
- Publication number
- BRPI1008188A2 BRPI1008188A2 BRPI1008188A BRPI1008188A BRPI1008188A2 BR PI1008188 A2 BRPI1008188 A2 BR PI1008188A2 BR PI1008188 A BRPI1008188 A BR PI1008188A BR PI1008188 A BRPI1008188 A BR PI1008188A BR PI1008188 A2 BRPI1008188 A2 BR PI1008188A2
- Authority
- BR
- Brazil
- Prior art keywords
- triazolopyridazine
- benzothiazoles
- sulfanyl
- medicines
- inhibitors
- Prior art date
Links
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0900513A FR2941951B1 (fr) | 2009-02-06 | 2009-02-06 | Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met. |
| PCT/FR2010/050179 WO2010089508A1 (fr) | 2009-02-06 | 2010-02-04 | Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1008188A2 true BRPI1008188A2 (pt) | 2016-03-08 |
Family
ID=40886773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1008188A BRPI1008188A2 (pt) | 2009-02-06 | 2010-02-04 | "derivados de 6-(6-nh-subistituído-triazolopiridazina-sulfanil) benzotiazóis e benzimidazóis: preparo, aplicação como medicamentos e utilização como inibidores de met" |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20120040987A1 (pt) |
| EP (1) | EP2393792A1 (pt) |
| JP (1) | JP2012517409A (pt) |
| KR (1) | KR20110126658A (pt) |
| CN (1) | CN102369192A (pt) |
| AR (1) | AR075250A1 (pt) |
| AU (1) | AU2010212233A1 (pt) |
| BR (1) | BRPI1008188A2 (pt) |
| CA (1) | CA2751539A1 (pt) |
| FR (1) | FR2941951B1 (pt) |
| IL (1) | IL214404A0 (pt) |
| MX (1) | MX2011008310A (pt) |
| RU (1) | RU2011136855A (pt) |
| SG (1) | SG173562A1 (pt) |
| TW (1) | TW201033214A (pt) |
| UY (1) | UY32421A (pt) |
| WO (1) | WO2010089508A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY34329A (es) | 2011-09-15 | 2013-04-30 | Novartis Ag | Compuestos de triazolopiridina |
| EA201590199A1 (ru) * | 2012-07-12 | 2015-05-29 | Санофи | Противоопухолевая композиция, содержащая соединение 1-(6-{[6-(4-фторфенил)[1,2,4]триазоло[4,3-b]пиридазин-3-ил]сульфанил}-1,3-бензотиазол-2-ил)-3-(2-морфолин-4-илэтил)мочевины |
| EP3942045A1 (en) | 2019-03-21 | 2022-01-26 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1298125A1 (en) | 2001-09-26 | 2003-04-02 | Aventis Pharma S.A. | Substituted benzimidazole compounds and their use for the treatment of cancer |
| CA2630884A1 (en) * | 2005-11-30 | 2007-06-07 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-met and uses thereof |
| ZA200804681B (en) * | 2005-11-30 | 2009-11-25 | Vertex Pharma Inc | Inhibitors of C-Met and uses thereof |
| HUE030390T2 (en) * | 2005-12-21 | 2017-05-29 | Janssen Pharmaceutica Nv | Triazolopyridazines as tyrosine kinase modulators |
| EP2032578A2 (en) * | 2006-05-30 | 2009-03-11 | Pfizer Products Incorporated | Triazolopyridazine derivatives |
| PE20080403A1 (es) * | 2006-07-14 | 2008-04-25 | Amgen Inc | Derivados heterociclicos fusionados y metodos de uso |
| CA2667428A1 (en) * | 2006-10-23 | 2008-05-02 | Sgx Pharmaceuticals, Inc. | Bicyclic triazoles as protein kinase modulators |
| PA8792501A1 (es) * | 2007-08-09 | 2009-04-23 | Sanofi Aventis | Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met. |
-
2009
- 2009-02-06 FR FR0900513A patent/FR2941951B1/fr not_active Expired - Fee Related
-
2010
- 2010-02-04 BR BRPI1008188A patent/BRPI1008188A2/pt not_active Application Discontinuation
- 2010-02-04 MX MX2011008310A patent/MX2011008310A/es not_active Application Discontinuation
- 2010-02-04 CN CN201080015591XA patent/CN102369192A/zh active Pending
- 2010-02-04 US US13/147,297 patent/US20120040987A1/en not_active Abandoned
- 2010-02-04 SG SG2011056512A patent/SG173562A1/en unknown
- 2010-02-04 RU RU2011136855/04A patent/RU2011136855A/ru unknown
- 2010-02-04 CA CA2751539A patent/CA2751539A1/fr not_active Abandoned
- 2010-02-04 AU AU2010212233A patent/AU2010212233A1/en not_active Abandoned
- 2010-02-04 EP EP10708279A patent/EP2393792A1/fr not_active Withdrawn
- 2010-02-04 JP JP2011548752A patent/JP2012517409A/ja not_active Withdrawn
- 2010-02-04 KR KR1020117020674A patent/KR20110126658A/ko not_active Withdrawn
- 2010-02-04 WO PCT/FR2010/050179 patent/WO2010089508A1/fr not_active Ceased
- 2010-02-05 UY UY0001032421A patent/UY32421A/es not_active Application Discontinuation
- 2010-02-05 TW TW099103591A patent/TW201033214A/zh unknown
- 2010-02-05 AR ARP100100318A patent/AR075250A1/es unknown
-
2011
- 2011-08-02 IL IL214404A patent/IL214404A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011008310A (es) | 2011-11-02 |
| CN102369192A (zh) | 2012-03-07 |
| JP2012517409A (ja) | 2012-08-02 |
| WO2010089508A1 (fr) | 2010-08-12 |
| KR20110126658A (ko) | 2011-11-23 |
| AR075250A1 (es) | 2011-03-16 |
| EP2393792A1 (fr) | 2011-12-14 |
| AU2010212233A1 (en) | 2011-08-25 |
| CA2751539A1 (fr) | 2010-08-12 |
| IL214404A0 (en) | 2011-09-27 |
| FR2941951B1 (fr) | 2011-04-01 |
| UY32421A (es) | 2010-09-30 |
| US20120040987A1 (en) | 2012-02-16 |
| SG173562A1 (en) | 2011-09-29 |
| RU2011136855A (ru) | 2013-03-20 |
| TW201033214A (en) | 2010-09-16 |
| FR2941951A1 (fr) | 2010-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1008232A2 (pt) | derivados de 6-(6-o-substituído- triazolo piridazina-sulfanil) benzotiazóis e benzimidazóis: preparo, aplicação como medicamentos e utilização como inibidores de met | |
| CY2019031I2 (el) | Αναπνευστικη απελευθερωση ενεργων παραγοντων | |
| HRP20190144T1 (hr) | Pripravci raav-gvanilat ciklaze i postupci za liječenje leberove urođene amauroze-1 (lca1) | |
| HUE039731T2 (hu) | l,3-difenilprop-2-én-l-on-származékok alkalmazása májbetegségek kezelésére | |
| IL214098A (en) | Derivatives of 2– (pyrolidine – 2 – il) - h1– benzimidazole, pharmaceutical preparations containing them and their use in the preparation of drugs | |
| SI2220030T1 (sl) | Derivati 4-(p-kuinonil)-2-hidroksibutanamida za zdravljenje mitohondrijskih bolezni | |
| IL226049A0 (en) | Composition for use in the prevention and/or treatment of skin conditions and skin diseases | |
| IL217540A (en) | Oral composition for use in oral disinfection or in treating an oral disease | |
| BR112013001603A2 (pt) | ''artigo absorvente descatável'' | |
| IL200639A0 (en) | Benzimidazole derivatives and methods of use thereof | |
| PL2338519T3 (pl) | Środek do leczenia zwłóknienia szpiku | |
| BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
| HRP20181608T1 (hr) | Korištenje inhibitora pde7 u liječenju bolesti kretanja | |
| EP2506967A4 (en) | NANOPARTICLE COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF | |
| FI20085693A0 (fi) | Biosignaalin prosessointi | |
| BRPI1014688A2 (pt) | aplicações terapêuticas de derivados de quinazolinadiona | |
| EP2532652A4 (en) | THERAPEUTIC AGENT AGAINST HEPATITIS C | |
| BR112012016492A2 (pt) | "artigo do vestuário descartavel" | |
| EP2305237A4 (en) | THERAPEUTIC AGENT FOR MALE STERILITY | |
| IL214408A0 (en) | Derivatives of 6-(6-substituted-triazolopyidazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors | |
| IL214404A0 (en) | Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl)benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors | |
| HRP20151393T8 (hr) | UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE | |
| UY33100A (es) | Derivados de 9h-beta-carbolina (o 9h-piridino (3,4-b) indol) trisustituidos, su preparacion y su utilizacion terapeutica | |
| IT1397212B1 (it) | Derivati di amminoalcoli e loro attivita' terapeutica | |
| BRPI1011354A2 (pt) | derivados de 6-(6-0-ciclo alquil ou 6-nh-ciclo alquil-triazolo piridazina sulfanil) benzotiazóis e benzimadazóis: preparo, aplicação como medicamentos e utilização como inibidores de met |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |